Lung, liver, kidney, skin, epidermis, endothelium, muscle, tendon, cartilage, heart, stomach, large intestine, small intestine, colon, uterus, nervous system, testis, adrenal gland, artery, vein, bile duct, or eye affecting fibers Certain quinoline compounds that are novel pharmaceutical therapies, and more particularly anti-angiogenic integrin α5β1 inhibitors, for use in the treatment of fibrosis or fibrosis related diseases, such as sexually transmitted diseases.肺、肝臓、腎臓、皮膚、表皮、内皮、筋肉、腱、軟骨、心臓、胃、大腸、小腸、結腸、子宮、神経系、精巣、副腎、動脈、静脈、胆管、又は眼に影響を及ぼす線維性疾患のような、線維症又は線維症関連疾患の治療に使用するための、新規医薬療法、より詳細には、抗血管新生性のインテグリンα５β１阻害剤である、ある種のキノリン化合物。
